Personal tools

FF:0000498: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{F5terms
{{F5terms
|id=FF:0000498
|alt_id=
|name=J2E erythroblastic leukemia line 0min after treatment with erythropoietin
|caged_opossum_mouse=http://cagedop.cmmt.ubc.ca/CAGEd_oPOSSUM/results/precomputed/mouse/FF:0000498/results.html
|namespace=FANTOM5
|def=
|xref=
|is_a=EFO:0001746;;FF:0000337;;FF:0000344;;FF:0000350;;FF:0000403
|synonym=
|comment=
|comment=
|alt_id=
|disjoint_from=
|union_of=
|created_by=
|created_by=
|obo_creation_date=
|def=
|subset=
|derives_from=
|derives_from=
|develops_from=
|develops_from=
|disjoint_from=
|has_quality=
|has_quality=
|id=FF:0000498
|is_a=EFO:0001746 ;;FF:0000337 ;;FF:0000344 ;;FF:0000350 ;;FF:0000403
|is_obsolete=
|located_in=
|located_in=
|name=mouse J2E erythroblastic leukemia line 0min after treatment with erythropoietin sample
|namespace=FANTOM5
|obo_creation_date=
|part_of=
|part_of=
|preceded_by=
|property_value=
|property_value=
|is_obsolete=
|subset=
|preceded_by=
|synonym=
|union_of=
|xref=
}}
}}

Latest revision as of 16:24, 18 April 2016

outline

  • id: FF:0000498
  • name: mouse J2E erythroblastic leukemia line 0min after treatment with erythropoietin sample
  • namespace: FANTOM5

Ontology association

Parents

is_a:EFO:0001746(development or differentiation design),FF:0000337(erythropoietin treatment sample),FF:0000344(0 minute sample),FF:0000350(experimentally modified sample),FF:0000403(mouse J2E erythroblastic leukemia cell line sample)

Children

is a:FF:13063-139I3 (J2E erythroblastic leukemia response to erythropoietin),FF:13129-140G6 (J2E erythroblastic leukemia response to erythropoietin),FF:13195-141E9 (J2E erythroblastic leukemia response to erythropoietin)

FF Samples

Mouse

  • 13063-139I3 (J2E erythroblastic leukemia response to erythropoietin)
  • 13129-140G6 (J2E erythroblastic leukemia response to erythropoietin)
  • 13195-141E9 (J2E erythroblastic leukemia response to erythropoietin)